We are live on ! Find out more
HSCSW icon

HeartSciences Inc Warrant
HSCSW

6 hedge funds and large institutions have $147K invested in HeartSciences Inc Warrant in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding

Funds holding: 2 → 6 (+4)

35% more capital invested

Capital invested by funds: $109K → $147K (+$38K)

1.51% more ownership

Funds ownership: 4.8% → 6.32% (+1.5%)

Holders
6
Holders Change
+4
Holders Change %
+200%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$9.39K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$8.5K
3
CS
Clear Street
New York
+$5.75K
4
UBS Group
UBS Group
Switzerland
+$100

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$101K – – –
CS
2
Clear Street
New York
$16K +$5.75K +17,221 +44%
CD
3
Chapin Davis
Maryland
$15.7K +$18.3K +55,000 New
Citadel Advisors
4
Citadel Advisors
Florida
$7.67K +$9.39K +28,154 New
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$6.94K +$8.5K +25,482 New
UBS Group
6
UBS Group
Switzerland
$87 +$100 +301 New

HSCSW Hedge Fund Activity: Q4 2022 in Review

6 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in HeartSciences Inc Warrant (HSCSW) for Q4 2022, worth a combined $147K — up 35% from $109K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new HSCSW positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $9.39K.

  • 6 institutional investors held HeartSciences Inc Warrant (HSCSW) as of Q4 2022, up from 2 in Q3 2022.
  • Funds reported $147K of HeartSciences Inc Warrant stock for Q4 2022, up 35% quarter-over-quarter.
  • 4 funds opened new HeartSciences Inc Warrant positions in Q4 2022 and 0 closed out, a net change of +4 holders.
  • The largest HeartSciences Inc Warrant buyer in Q4 2022 was Citadel Advisors, an estimated $9.39K added.

Based on aggregated 13F filings for Q4 2022.